GlycoMimetics
(NASDAQ:GLYC)
$2.30
0.045[2.00%]
Last update: 8:26AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

GlycoMimetics Stock (NASDAQ:GLYC), Quotes and News Summary

GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.

Open$2.240
Close-
Volume / Avg.180.802K / 390.973K
Day Range2.220 - 2.330
52 Wk Range1.110 - 3.530
Market Cap$148.236M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest
3.56%
Days to Cover3.7

Recent News

Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket
Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024. Trinity Place shares jumped 80.1% to $0.2056 in pre-market trading.
Avi Kapoor
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Lisa Levin
Why Provention Bio Shares Are Trading Higher By Over 260%; Here Are 20 Stocks Moving Premarket
Gainers Provention Bio, Inc. (NASDAQ: PRVB) rose 262.7% to $24.30 in pre-market trading after Sanofi agreed to acquire the company for $25.00 per share in cash, representing an equity value of approximately $2.9 billion.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About GlycoMimetics Inc
Sector
Health Care
Industry
Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and deve...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GLYC
SYRS

FAQ

Q

How do I buy GlycoMimetics (GLYC) stock?

A

You can purchase shares of GlycoMimetics (NASDAQ: GLYC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are GlycoMimetics's (GLYC) competitors?

A

Other companies in GlycoMimetics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Zura Bio (NASDAQ:ZURA), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX) and FibroGen (NASDAQ:FGEN).

Q

What is the target price for GlycoMimetics (GLYC) stock?

A

The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on Wednesday, March 27, 2024. The analyst firm set a price target for 8.00 expecting GLYC to rise to within 12 months (a possible 249.34% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for GlycoMimetics (GLYC)?

A

The stock price for GlycoMimetics (NASDAQ: GLYC) is $2.29 last updated Today at April 16, 2024 at 10:37 AM EDT.

Q

Does GlycoMimetics (GLYC) pay a dividend?

A

There are no upcoming dividends for GlycoMimetics.

Q

When is GlycoMimetics (NASDAQ:GLYC) reporting earnings?

A

GlycoMimetics’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Q

Is GlycoMimetics (GLYC) going to split?

A

There is no upcoming split for GlycoMimetics.

Q

What sector and industry does GlycoMimetics (GLYC) operate in?

A

GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch